A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes.
about
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cellsExpression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.Cancer/testis antigens: structural and immunobiological properties.Novel designs of single-chain MHC I/peptide complex for the magnetosome display system.Expression, purification and serological analysis of hepatocellular carcinoma associated antigen HCA587 in insect cellsGenetic modification of human T lymphocytes for the treatment of hematologic malignancies.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancerEnhancing cancer immunotherapy by intracellular delivery of cell-penetrating peptides and stimulation of pattern-recognition receptor signaling.Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.Immune targets and neoantigens for cancer immunotherapy and precision medicine.Identification of novel MAGE-A6- and MAGE-A12-derived HLA-A24-restricted cytotoxic T lymphocyte epitopes using an in silico peptide-docking assay.Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.A MAGE-1 peptide recognized on HLA-DR15 by CD4(+) T cells.Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.Expression of MAGE-B genes in esophageal squamous cell carcinoma.
P2860
Q24804892-5FF8DB44-CF6C-4E5D-A693-B14C552875C9Q30706370-57B5317F-0653-4FE9-9490-49D559C81CCBQ34568997-DCA6CBAC-17FC-4AE6-A23B-267693BEA8FCQ35540721-05D65BEB-9E8C-4C5E-9903-DA94D17A8E8DQ36178619-86ECC1EB-1B47-44EE-916C-93110F560178Q36366557-06F38ED3-8608-4EF4-895F-008C0DCF1F5DQ36471831-C7D27231-69FA-4541-A5DD-87A287FC4763Q36610975-14D3BF73-D321-498E-A6D1-9C9DA446B2E0Q37139813-1AC01066-8CA3-4483-89A1-EDFDAE7BE33EQ38305306-3514E217-D561-4DF1-943E-4F24E5EFFCBEQ39057617-A0FBED5A-95DD-4BC9-9CFF-D70CD74A8895Q39329649-213812AC-34DF-4532-9411-CC5E417FFF04Q40085654-F9819DA8-DF88-4556-873A-510A779817AEQ40795446-07F8DE3E-7D0E-40CA-8FB4-4563A72BA2A9Q40812116-4E0223AE-5862-4AFA-90C6-A0D3002A1F61Q44269708-45957633-87F1-4E62-B351-7D66A705B7B0Q51013344-DF85EF52-FE89-4D4B-AD74-D3F519459AEDQ54935981-D8202C32-CF3B-4481-930A-04EF57F97523
P2860
A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
A MAGE-1-encoded HLA-A24-bindi ...... tumor cytotoxic T lymphocytes.
@en
type
label
A MAGE-1-encoded HLA-A24-bindi ...... tumor cytotoxic T lymphocytes.
@en
prefLabel
A MAGE-1-encoded HLA-A24-bindi ...... tumor cytotoxic T lymphocytes.
@en
P2093
P1476
A MAGE-1-encoded HLA-A24-bindi ...... tumor cytotoxic T lymphocytes.
@en
P2093
P304
P356
10.1002/(SICI)1097-0215(19990118)80:2<169::AID-IJC1>3.0.CO;2-P
P577
1999-01-01T00:00:00Z